Skip to main content
. 2010 Oct 25;107(44):18769–18776. doi: 10.1073/pnas.1008501107

Fig. 2.

Fig. 2.

Western blot analysis of immunoaffinity purified HLA-I molecules. A: Plasma sHLA-I from peripheral blood and bone marrow from MM patient #1 and #2, AML-1 patient, and healthy 1 control. B: sHLA-I from the conditioned medium of MM cell lines: U266, L363, and RPMI8226, and the mHLA-I from the MM cell lines and from AML-1 cells.